Alzheimer’s research is latest casualty in Trump administration war against ‘DEI’

Grant cancellations at leading research institutions appear to target study of impacts of racism on brain health A new round of scientific grant cancellations has hit brain health and Alzheimer’s disease research at two leading research institutions, Emory University and the University of Pittsburgh. The latest cancellations are the Trump administration’s most recent effort to remove disfavored topics from the National Institutes of Health (NIH) $47bn scientific portfolio – and appear to target the study of the impacts of racism. “This kind of clear political interference – that’s not a good way to do science,” said Ann Cohen, an associate professor of psychiatry at the University of Pittsburgh, whose grant was canceled. “I haven’t even thought much about the why this is being done because it’s so scientifically wrong that I can’t get past that piece.” Cohen, and all researchers the Guardian interviewed, spoke in their personal capacity. The Guardian has contacted representatives of the US Department of Health and Human Services, which oversees the NIH, for an explanation of the cancellations. It did not receive a response. At least three grants were cancele